TAINAN, Taiwan I June 12, 2025 I Merry Life Biomedical Company announces the launch of its global Phase II clinical trial for TML-6, a novel oral small ...

HAMPTON, NJ, USA I June 12, 2025 I Celldex (NASDAQ:CLDX) announced today new data demonstrating profound, sustained complete response and improved quality of ...

LONDON, UK I June 13, 2025 I GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency (EMA) has accepted the company’s regulatory ...

BAGSVAERD, Denmark I June 12, 2025 I Novo Nordisk today announced that it will advance subcutaneous and oral amycretin into phase 3 development in weight ...

STOCKHOLM, Sweden I June 13, 2025 I BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) announced today that the interim safety review of the clinical Phase 2a ...

LONDON, UK I June 12, 2025 I GSK plc (LSE/NYSE: GSK) announced today that it has licensed its Shigella vaccine candidate, altSonflex1-2-3, to Bharat Biotech ...

REDWOOD CITY, CA, USA I June 11, 2025 I Juvena Therapeutics, Inc. (“Juvena”), a clinical-stage biotechnology company pioneering tissue restorative biologics ...

MAINZ and TÜBINGEN, Germany I June 12, 2025 I BioNTech SE (Nasdaq: BNTX, “BioNTech”) and CureVac N.V. (Nasdaq: CVAC, “CureVac”) today announced that they ...

KRAKOW, Poland I June 12, 2025 I Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel therapies that ...

BOSTON, MA, USA I June 12, 2025 I EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, a leading science and ...

LEHI, UT, USA I June 12, 2025 I Biolexis Therapeutics, Inc. ( a clinical-stage therapeutics company pioneering next-generation treatments ...

Company to discuss glycan-targeting ADC platform during BIO International Convention 2025. NEW TAIPEI CITY, Taiwan I June 12, 2025 I GlycoNex, Inc. (4168, hereinafter referred to ...